STAT

JULY 6, 2024

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

296

296

Express Pharma

JULY 6, 2024

The hemp industry in India is expanding rapidly, but there are several obstacles standing in its way. These include strict rules and regulations and a lot of misinformation. The sector can only flourish if the government provides backing in the form of legalisation and awareness campaigns on hemp and its products. Focusing on sustainable development and a defined course of action will establish India as a leader in the global hemp market and encourage ethical practices.

Labelling 119

Labelling 119

Drug Patent Watch

JULY 6, 2024

China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […] Source

86

86

PharmaTech

JULY 6, 2024

The increased demand for biopharmaceutical products is increasing the demand for lyophilization innovations and services.

69

69

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Drug Patent Watch

JULY 6, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

59

59

Pharma Mirror

JULY 6, 2024

Ensuring the safety and efficacy of pharmaceutical products is paramount in the healthcare industry. Pharmaceutical impurity reference standards play a critical role in this process by helping to identify and quantify impurities. Understanding their importance can significantly enhance quality control measures in drug development and production. In today’s pharmaceutical industry, maintaining high-quality standards is not just a regulatory requirement but also an ethical obligation.

Drug Development 52

Drug Development 52

Drug Patent Watch

JULY 6, 2024

This chart shows the pharmaceutical companies with the most insert dosed drugs. For a different perspective, see the most popular dosage types.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Dosage 59

Pharmacy Times

JULY 6, 2024

Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.

Drug Development 37

Drug Development 37